お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
757074

欧州の患者エンゲージメント2.0 (Patient Engagement 2.0):2018年

The Future of Patient Engagement 2.0 in Europe, 2018

出版日: | 発行: Frost & Sullivan | ページ情報: 英文 109 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.68円
欧州の患者エンゲージメント2.0 (Patient Engagement 2.0):2018年
出版日: 2018年11月30日
発行: Frost & Sullivan
ページ情報: 英文 109 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

現在の医療は、単に病院に行くだけの消極的なアプローチから、意識の高い患者自身がより積極的にかかわるアプローチへとシフトしています。医療にかかわる従来の様式は、新しい文化的意識や携帯電話、スマートフォン、ソーシャルメディアの広い普及、また、医療提供者によるデジタルツール利用の拡大などの要因によって、大きく作り変えられています。

当レポートでは、欧州の患者エンゲージメント2.0 (Patient Engagement 2.0) の市場を調査し、デジタルヘルス、患者エンゲージメント、患者エンゲージメント 2.0の定義・概要・実現技術、市場成長への各種影響因子の分析、ベンダーマッピング、ステークホルダー区分別の動向、ケーススタディ、成長機会の分析などをまとめています。

第1章 エグゼクティブサマリー

第2章 デジタルヘルス産業の概要

  • デジタルヘルスのメリット
  • デジタルヘルスの優先度
  • デジタルヘルスの分類と融合

第3章 患者エンゲージメント:概要

  • 定義
  • 医療エコシステムにおける患者の役割の進化
  • 消費者のもっとも重要と考える価値
  • 患者エンゲージメントの実現技術
  • 患者エンゲージメント 2.0に貢献するデジタルヘルス製品・サービス
  • 患者エンゲージメントツールのマッピング:段階別
  • 患者エンゲージメント:主なメリット
  • 患者に力を与える機会

第4章 市場力学:成長推進因子・成長抑制因子・メガトレンド

  • 成長推進因子
  • 成長阻害因子
  • 主要動向
  • 消費者グレードウェアラブルの医療グレード化
  • GDPRの顕著な特徴
  • GDPRの患者エンゲージメントへの影響

第5章 ベンダー環境

  • 患者エンゲージメント 2.0に貢献するデジタルヘルス製品・サービス
  • ベンダーマッピング:主要機能別
  • ベンダー分析:戦略・強み・例
  • ベンダーの取り組みマッピング
  • 主要スタートアップ企業

第6章 国別分析:プッシュ&プル因子の分析

  • ECの影響
  • 国別の魅力
  • 欧州におけるソリューション機会マップ
  • 市場機会・課題
    • エストニア
    • オランダ
    • 北欧諸国
    • 英国
    • スペイン

第7章 患者エンゲージメントと主要ステークホルダー

  • 患者エンゲージメントとヘルスケアステークホルダー
  • 主要デジタルヘルスツールの普及分析
  • 将来の成長機会:用途別

第8章 患者エンゲージメントと医療提供者

  • 医療提供者:課題・市場推進因子・用途・成長エリアの概要
  • デジタルヘルスソリューションの相対的利用動向
  • 将来の成長機会
  • ケーススタディ:デジタルヘルスソリューションによる転帰の改善

第9章 患者エンゲージメントと医薬品産業

  • 医薬品産業:課題・市場推進因子・用途・成長エリアの概要
  • 創薬・開発サイクルを通じた患者エンゲージメント
  • 主要企業によるデジタルヘルスツールの利用例
  • 将来の成長機会

第10章 患者エンゲージメントと医療技術産業

  • 医療技術産業 (デバイス・診断技術):課題・市場推進因子・用途・成長エリアの概要
  • 主要企業によるデジタルヘルスツールの利用例
  • 将来の成長機会

第11章 患者エンゲージメントと保険者

  • 医療費支払い者と保険者:課題・市場推進因子・用途・成長エリアの概要
  • 主要企業によるデジタルヘルスツールの利用例
  • 将来の成長機会

第12章 成長機会・推奨行動

  • 成長機会
  • 成功・成長の戦略的必須要件

第13章 総論

  • 三大予測
  • 免責事項

第14章 付録

第15章 FROST & SULLIVANについて

目次
Product Code: ME0C-48

There is Something for Everyone-Growth Opportunities for Stakeholders Across the Healthcare Ecosystem in Europe

Healthcare today is not about just going to the doctor at the time of illness or on regular appointments to check the overall disease progression. It is shifting to a more proactive rather than reactive approach with patients being more aware and willing to be involved in their own health. The traditional culture of healthcare and how people engage in healthcare is being dramatically reshaped by new cultural attitudes and the pervasive adoption of mobile phones/smartphones/social media by the general population as well as digital health tools increasingly used by healthcare providers. This opens up new possibilities for reshaping behaviors, especially for younger demographics. Further, health systems around the world are reeling under the pressure of rising costs, shortage of personnel, and the ever-increasing burden of chronic ailments.

Digital health solutions are the saviors in such a landscape driving Patient Engagement 2.0. Not only do the IT solutions empower the patients, they also provide a cost-effective alternate channel for managing chronic patients. Broadly, digital health solutions cater to patient touch points across the care continuum and target clinical (remote monitoring, telehealth etc.), administrative (appointment scheduling, reminders etc.), and financial (billing, payer communications etc.) functions. A plethora of pure-play patient engagement companies are offering innovative solutions. EHR providers and medical device companies are not far behind. Different vendor types are targeting different gaps in the care journey. Innovations and start-up activity is abundant in this area with trends such as healthcare consumerization shaping up. Increasingly, there is a demand for clinical-grade digital solutions which offer the ease of use of consumer-grade devices and the accuracy and efficacy of medical-grade ones. Europe is emerging as a strong market with some countries becoming more attractive for such solutions. The regulatory framework of countries, IT infrastructure, and sociocultural factors have a major impact on the uptake of patient engagement solutions.

The value of engaging patients digitally is not just being seen among the healthcare providers, but also with medical diagnostics, devices, pharmaceuticals, and insurance providers. As the report title reads, ‘There is something for everyone'. The stakeholders of the healthcare ecosystem should not look at patient engagement as a one-time activity, but as a cultural shift in the change of mind set and way of life. This report covers the current scenario for patient engagement in Europe and among stakeholders and also delves into growth opportunity areas for vendors to exploit in the next five years.

Table of Contents

1. EXECUTIVE SUMMARY

  • Definition of Patient Engagement
  • Key Findings
  • Vendor Activity Mapping across the Care Continuum
  • Growth Opportunities
  • Strategic Imperatives for Success and Growth
  • CEO's Perspective
  • Three Big Predictions
  • Scope and Segmentation
  • Key Questions this Study will Answer

2. DIGITAL HEALTH INDUSTRY SNAPSHOT

  • Digital Health Benefits from Broader Industry Convergence
  • Digital Health Priorities
  • Digital Health Market Segmentation and Convergence

3. DECODING PATIENT ENGAGEMENT

  • Definition
  • Patients' Evolving Role in the Healthcare Ecosystem
  • What Do Consumers Value Most?
  • Enabling Technologies for Patient Engagement
  • Digital Health Products and Services that Contribute to Patient Engagement 2.0
  • Mapping of Patient Engagement Tools by Stages of the Healthcare Journey
  • Patient Engagement-Key Benefits
  • Opportunities to Empower Patients

4. MARKET DYNAMICS-DRIVERS, RESTRAINTS, ANDMEGA TRENDS

  • Market Drivers
  • Drivers Explained
  • Drivers Explained (continued)
  • Market Restraints
  • Restraints Explained
  • Restraints Explained (continued)
  • Key Trends Impacting the Patient Engagement Space
  • Key Trends Impacting the Patient Engagement Space (continued)
  • Consumer-grade Wearables Working Towards Being Recognized as Medical-grade Wearables
  • Salient Features of the GDPR
  • How Does GDPR Impact Patient Engagement?

5. VENDOR LANDSCAPE

  • Digital Health Products and Services that Contribute to Patient Engagement 2.0
  • Vendor Mapping across Key Functional Categories
  • Vendor Analysis-Strategy Outlook, Top Strengths, Examples
  • Vendor Analysis-Strategy Outlook, Top Strengths, Examples (continued)
  • Vendor Analysis-Strategy Outlook, Top Strengths, Examples (continued)
  • Vendor Analysis-Strategy Outlook, Top Strengths, Examples (continued)
  • Vendor Analysis-Strategy Outlook, Top Strengths, Examples (continued)
  • Vendor Analysis-Strategy Outlook, Top Strengths, Examples (continued)
  • Vendor Activity Mapping across the Care Continuum
  • Key Start-Ups-New and Innovative Market Entrants

6. COUNTRY ANALYSIS-PUSH AND PULL FACTOR ANALYSIS FOR SELECT COUNTRIES

  • Impetus by the EU Commission to Incorporate Digital Health Solutions to Provide Better Healthcare Services Across Europe
  • Country-specific Attractiveness for Patient Engagement
  • Patient Engagement-Solution Opportunity Map in Europe
  • Estonia-Opportunities and Challenges
  • The Netherlands-Opportunities and Challenges
  • Nordics-Opportunities and Challenges
  • The United Kingdom-Opportunities and Challenges
  • Spain-Opportunities and Challenges

7. PATIENT ENGAGEMENT WITH KEY STAKEHOLDERS

  • Patient Engagement and Healthcare Stakeholders
  • Assessing The Penetration of Key Digital Health Tools
  • Future Growth Opportunities With Respect to Applications

8. PATIENT ENGAGEMENT AND HEALTHCARE PROVIDERS

  • Healthcare Providers-Overview of the Problem, the Market Propellers, the Applications, and Growth Areas
  • Relative Usage of Digital Health Solutions by Function across the Patient Journey
  • Future Growth Opportunities
  • Future Growth Opportunities (continued)
  • Case Studies of Outcomes Improvement with Digital Health Solutions

9. PATIENT ENGAGEMENT AND THE PHARMACEUTICAL INDUSTRY

  • Pharmaceutical Industry-Overview of the Problem, the Market Propellers, the Applications and Growth Areas
  • Pharmaceutical Companies Can Engage Patients Throughout the Drug Discovery and Development Cycle
  • Examples of the Usage of Digital Health Tools by Some Pharma Companies
  • Future Growth Opportunities

10. PATIENT ENGAGEMENT AND THE MEDICAL TECHNOLOGY INDUSTRY

  • Medical Technology Industry (Devices and Diagnostics)-Overview of the Problem, the Market Propellers, the Applications and Growth Areas
  • Examples of the Usage of Digital Health Tools by Key Med-tech Companies
  • Future Growth Opportunities

11. PATIENT ENGAGEMENT AND THE PAYER SEGMENT

  • Healthcare Payers and Insurance Providers-Overview of the Problem, the Market Propellers, the Applications and Growth Areas
  • Usage of Digital Health Tools by Key Med-tech Companies
  • Future Growth Opportunities

12. GROWTH OPPORTUNITIES AND COMPANIES TO ACTION

  • Growth Opportunities
  • Strategic Imperatives for Success and Growth

13. THE LAST WORD

  • Three Big Predictions
  • Legal Disclaimer

14. APPENDIX

  • Country Analysis-Infrastructure and Health IT Adoption
  • Country Analysis-Infrastructure and Health IT Adoption (continued)
  • Country Analysis-Regulations and Policy
  • Country Analysis-Regulations and Policy (continued)
  • Country Analysis-Sociocultural Factors
  • Country Analysis-Sociocultural Factors (continued)
  • Country Analysis-Health Systems Factors
  • Country Analysis-Health Systems Factors (continued)
  • List of Exhibits

15. THE FROST & SULLIVAN STORY

  • The Frost & Sullivan Story
  • Value Proposition-Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.